Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. scores highest on Nitro (68) and lowest on Price (31). Its PosiPenta is 52.51 out of 100, around the middle of similar companies.
On the Penta Grid this week, Atea Pharmaceuticals, Inc. is Grid #242 of 837 in the Healthcare sector in United States, and Grid #1,585 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | 52.51 | 31 | 37 | 68 | 63 | 64 |
| Orchestra BioMed Holdings, Inc. | 38.47 | 4 | 31 | 84 | 8 | 66 |
| Alpha Teknova, Inc. | 50.71 | 11 | 58 | 80 | 48 | 56 |
| Emergent BioSolutions Inc. | 41.51 | 40 | 53 | 45 | 33 | 37 |
| Nautilus Biotechnology, Inc. | 46.30 | 29 | 37 | 53 | 49 | 63 |
| Opus Genetics, Inc. | 38.88 | 0 | 48 | 59 | 27 | 60 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.07 |
| P/B ratio | 1.70 |
EEarnings
| Trailing EPS | ₹-197.95 |
| Forward EPS | ₹-140.18 |
NNitro
| Price | 409.17 |
| 52-week high | 610.91 |
| 52-week low | 271.83 |
| Fall from 52-week high | 33.0% |
TTorque
| Return on equity (ROE) | -58.14% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.39 |
| Market cap | ₹3,281 Cr |
| Insider holding | 13.37% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Atea Pharmaceuticals, Inc.'s PosiPenta score?
Atea Pharmaceuticals, Inc.'s PosiPenta is 52.51 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Atea Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Atea Pharmaceuticals, Inc. is Grid #242 of 837 in the Healthcare sector in United States, and Grid #1,585 of 4,000 in United States.
Which PosiPenta pillar is strongest for Atea Pharmaceuticals, Inc.?
Nitro (momentum), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Atea Pharmaceuticals, Inc.?
Price (valuation), with a score of 31 out of 100: weaker than most similar companies.
Has Atea Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.75 points, from 50.76 to 52.51.
PositoAI is for research and education only and is not investment advice.